NCT03517813View on ClinicalTrials.gov

CESM ABMR Breast Cancer Screening Trial

CompletedOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

June 22, 2021

Study Completion Date

December 31, 2022

Conditions
Breast Cancer Screening
Interventions
DEVICE

Contrast-enhanced Spectral Mammography (CESM)

Dual energy mammography images obtained after the administration of an intravenous contrast agent

Trial Locations (1)

98102

Seattle Cancer Care Alliance, Seattle

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

University of Washington

OTHER